Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia

NCT02573363 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Cytarabine
DRUG: Mitoxantrone Hydrochloride
DRUG: Selinexor

Sponsor

University of Chicago

Collaborators

[object Object]